title: A homoharringtonine-based regimen for childhood acute myelogenous leukemia.
authors.affiliation: Department of Hematology/Oncology, Xin Hua Hospital/Shanghai Children's Medical Center, Shanghai Second Medical University. yantfk@online.sh.cn
authors.forename: JingYan
authors.initials: J
authors.lastname: Tang
authors.forename: Huiliang
authors.initials: H
authors.lastname: Xue
authors.forename: Ci
authors.initials: C
authors.lastname: Pan
authors.forename: Jing
authors.initials: J
authors.lastname: Chen
authors.forename: LongJun
authors.initials: L
authors.lastname: Gu
authors.forename: HuiJun
authors.initials: H
authors.lastname: Zhao
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002681:China; D003561:Cytarabine / Q000008:administration & dosage; D018572:Disease-Free Survival; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006248:Harringtonines / Q000008:administration & dosage*; D000077863:Homoharringtonine; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality*; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000401:mortality*; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D006248:Harringtonines; D003561:Cytarabine; D000077863:Homoharringtonine; D005047:Etoposide